Immuno-genetic screening to improve cancer therapies and developing novel antibody drugs 1-10 Employees
- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- Website
- Locations
- Company size
- 1-10 people
- Total raised
- $150K
- Company type
- Private Company
- Markets
Svastia Genetics Funding
$150K
11 round
500 Global
Funding Rounds
PRE
$150,000Pre-SeedFeb 2019
Investors of Svastia Genetics
500 Global is a venture capital firm that has invested in 2500+ cos across 77 countries
Rounds
PRE